PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Mesencephalic Astrocyte-Derived Neurotrophic Factor Prevents Traumatic Brain Injury in Rats by Inhibiting Inflammatory Activation and Protecting the Blood-Brain Barrier.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29883817 ↗2018Reported benefit

Mesencephalic Astrocyte-Derived Neurotrophic Factor Prevents Traumatic Brain Injury in Rats by Inhibiting Inflammatory Activation and Protecting the Blood-Brain Barrier.

RatTBIWeight-drop / impact-accelerationSprague-DawleyMaleHigh dose 20 micrograms in 20 microlitresAdministered after traumatic brain injury, with assessment 24 hours later

Model: Feeney free-falling weight-drop traumatic brain injury

High-dose recombinant human MANF increased the modified Garcia score and reduced brain water content and cerebral oedema volume, lowered blood-brain barrier permeability and reduced interleukin 1 beta and tumour necrosis factor alpha expression, with inhibition of P65 activation.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.